Marco Valgimigli
Cardiocentro Ticino · Cardiocentro Ticino Institute · Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano,
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
19
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
217
PubMed author-name match
Trials
Studies that name Marco Valgimigli as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:46 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07582835 · Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.Cardiocentro Ticino · recruiting · Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndromes · principal investigator
- N/ANCT07514962 · Minimally Invasive Coronary Artery Bypass Supported by CangrelorCardiocentro Ticino · recruiting · Coronary Artery Disease, Antiplatelet Therapy, Minimally Invasive Coronary Revascularization Surgery · principal investigator
- Ph4NCT05955365 · Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent ImplantationInsel Gruppe AG, University Hospital Bern · recruiting · Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation · principal investigator
- N/ANCT05696873 · CoPing strategIes-psyChological flexibiliTy in Patients Hospitalized for Ischemic cardiovascUlaR disEase (PICTURE)Cardiocentro Ticino · unknown · Ischemic Cardiovascular Disease · principal investigator
- Ph4NCT05674630 · Ticin for the Treatment of Coronary Lesions With Drug Eluting BallonsCardiocentro Ticino · recruiting · Chronic Coronary Syndrome · principal investigator
- Ph4NCT04137510 · Bioflow-DAPT StudyBiotronik AG · completed · Coronary Artery Disease · principal investigator
- N/ANCT03399851 · Comparison of Amplatzer Amulet and Watchman Device in Patients Undergoing Left Atrial Appendage Closure. (SWISS-APERO)Insel Gruppe AG, University Hospital Bern · unknown · Left Atrial Appendage Closure · study chair
- N/ANCT03355742 · XIENCE 28 Global StudyAbbott Medical Devices · completed · Bleeding Disorder, Stroke, Ischemic, Stroke Hemorrhagic · principal investigator
- N/ANCT03231059 · GLOBAL LEADERS Adjudication Sub-StudyInsel Gruppe AG, University Hospital Bern · completed · Coronary Artery Disease, Platelet-aggregation Inhibitors · principal investigator
- Ph4NCT02978040 · Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.Insel Gruppe AG, University Hospital Bern · completed · Coronary Artery Disease, STEMI - ST Elevation Myocardial Infarction · study chair
- Ph4NCT02587260 · Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function in Humans (HI-TECH)Erasmus Medical Center · completed · Cardiovascular Diseases · principal investigator
- N/ANCT02325973 · Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCIAbbott Medical Devices · completed · Multi Vessel Coronary Artery Disease, STEMI · study chair
- Ph4NCT01477775 · Customized Choice of Oral P2Y12 Receptor BlockerItalian Society of Invasive Cardiology · unknown · Acute Coronary Syndrome, Coronary Angioplasty · principal investigator
- Ph3NCT01433627 · Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioXItalian Society of Invasive Cardiology · unknown · Acute Coronary Syndromes, STEMI, NSTEMI · principal investigator
- N/ANCT01271309 · Stem Cell Migratory Activity: Prognostic Marker in Myocardial IschemiaIRCCS Multimedica · completed · Myocardial Infarction · principal investigator
- N/ANCT01122719 · Brazilian and Italian Evaluation of Safety Using Tacrolimus-eluting Stent With Short-term Dual Antiplatelet RegimenCID - Carbostent & Implantable Devices · terminated · Stable Coronary Disease, Unstable Coronary Disease, Documented Silent Ischemia · principal investigator
- Ph4NCT00611286 · Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary InterventionMarco Valgimigli · completed · Coronary Artery Disease · principal investigator
- Ph3NCT00597324 · Predictive Value of Allen's Test Result in Elective Patients Undergoing Coronary Catheterization Through Radial ApproachMarco Valgimigli · completed · Coronary Artery Disease · principal investigator
- Ph4NCT00398463 · Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel ResistanceUniversità degli Studi di Ferrara · completed · Angioplasty, Transluminal, Percutaneous Coronary · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:46 UTC. The ranking covers the 200 most relevant of 217 PubMed records, and a shared surname and initials can bring in a namesake. All 217 on PubMed
- 1,031 citationsRCR 38.1
- 664 citationsRCR 25.3
- Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.N Engl J Med · 2012629 citationsRCR 17.7
- Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial.Circulation · 2012581 citationsRCR 15.7
- 531 citationsRCR 23.8
- Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.N Engl J Med · 2021492 citationsRCR 30.1
- 425 citationsRCR 22.6
- Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes.N Engl J Med · 2015309 citationsRCR 9.7
- 300 citationsRCR 11.1
- 292 citationsRCR 9.5